Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem (SM-7338) for treatment of bacterial meningitis
jRCT2080221609Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of meropenem in bacterial meningitis, sponsored by Sumitomo Pharma.
02
Drugs
meropenem
03
Conditions
bacterial meningitis
Beyond the preview
Go deeper on jRCT2080221609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221609.